2 reports

  • 3.4 FORECAST METHODOLOGY

[Accessed November ##, 2015].

  • Cancer
  • Lymphoma
  • Pathology
  • Spain
  • Forecast

The exchange ratio between the shares of the two companies was ##:##, one Pharma Mar share for each Zeltia share.

  • Lymphoma
  • Pharmaceutical
  • Spain
  • Company
  • Pharma Mar, S.A.